ResMed Inc (RMD)
$200.37+0.89%
Spriggl Score: Strong— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Sleep therapy leader expanding into RLS; GLP-1 fears disproved, balance sheet pristine, decades of demand runway.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and …
- Sector:
- Healthcare
- Industry:
- Medical Instruments & Supplies
- Market Cap:
- $27.4B
Recent dividends
- 14 May 2026$0.60
- 12 Feb 2026$0.60
- 13 Nov 2025$0.60
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across ResMed Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free